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Mitochondrial perturbation and oxidative stress are key factors in neuronal vulnerability in several neuro-
degenerative diseases or during brain ischemia. Here we have investigated the protective mechanism of
action of guanosine, the guanine nucleoside, in a human neuroblastoma cell line, SH-SY5Y, subjected to
mitochondrial oxidative stress. Blockade of mitochondrial complexes I and V with rotenone plus oligomy-
cin (Rot/oligo) caused a signiﬁcant decrease in cell viability and an increase in ROS production. Guanosine
that the protective effect of guanosine incubated concomitantly with Rot/oligo abolished Rot/oligo-
induced cell death and ROS production in a concentration dependent manner; maximum protection was
achieved at the concentration of 1 mM. The cytoprotective effect afforded by guanosine was abolished
by adenosine A1 or A2A receptor antagonists (DPCPX or ZM241385, respectively), or by a large (big) conduc-
tance Ca2+-activated K+ channel (BK) blocker (charybdotoxin). Evaluation of signaling pathways showed
that the protective effect of guanosine was not abolished by a MEK inhibitor (PD98059), by a p38MAPK
inhibitor (SB203580), or by a PKC inhibitor (cheleritrine). However, when blocking the PI3K/Akt pathway
with LY294002, the neuroprotective effect of guanosine was abolished. Guanosine increased Akt and p-
Ser-9-GSK-3b phosphorylation conﬁrming this pathway plays a key role in guanosine’s neuroprotective
effect. Guanosine induced the antioxidant enzyme heme oxygenase-1 (HO-1) expression. The protective
effects of guanosine were prevented by heme oxygenase-1 inhibitor, SnPP. Moreover, bilirubin, an antiox-
idant and physiologic product of HO-1, is protective against mitochondrial oxidative stress. In conclusion,
our results show that guanosine can afford protection against mitochondrial oxidative stress by a signaling
pathway that implicates PI3K/Akt/GSK-3b proteins and induction of the antioxidant enzyme HO-1.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
In the central nervous system (CNS) guanosine, the endogenous
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sevier OA license.from glial cells. In astrocytic cell cultures it has been reported that
guanine nucleotides and guanosine can be released under basal or
toxic conditions (Ciccarelli et al., 1999, 2001). Alternatively, nucle-
otides such as GTP, GDP and GMP can be metabolized by ecto-
nucleotidases to produce extracellular guanosine (Caciagli et al.,
2000; Ciccarelli et al., 2001). Guanosine and guanine nucleotides
have been implicated in neuroprotection by exerting trophic ef-
fects (Ciccarelli et al., 2001; Decker et al., 2007), as well as by coun-
teracting glutamate excitotoxicity in vitro (Molz et al., 2005, 2008;
Oleskovicz et al., 2008) and in vivo (Schmidt et al., 2000, 2005,
2007). Guanosine also protects cultured rat astrocytes from stauro-
sporine-induced apoptosis (Di Iorio et al., 2004) and SH-SY5Y cells
from b-amyloid-induced apoptosis (Pettifer et al., 2004). In both
cases, the anti-apoptotic effect of guanosine was mediated by stim-
ulation of phosphatidylinositol-3-kinase (PI3K)/protein kinase B
(Akt) and mitogen-activated protein kinase (MAPK) cell survival
pathways.
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extracellular site of interaction and mechanisms of action for this
nucleoside have not yet been fully characterized. Some studies
suggest that guanosine participates in cell proliferation, neurite
outgrowth and cellular protection by a mechanism that involves
activation of adenosine receptors (Ciccarelli et al., 2000; D’Alimonte
et al., 2007; Thauerer et al., 2010). However, we have recently
demonstrated that guanosine-induced protection in hippocampal
slices subject to oxygen/glucose deprivation depends on large con-
ductance Ca2+-activated K+ (BK) channels activation (Dal-Cim et al.,
2011).
Oxidative stress is a common mechanism of cell death in dis-
tinct cytotoxic models such as glutamate (Parfenova et al., 2006),
b-amyloid (Tamagno et al., 2006), MPP+ (Nicotra and Pavrez,
2000), or hydrogen peroxide-induced cytotoxicity (Kim et al.,
2005). Oxidative stress has also been related to neurodegenerative
diseases like Alzheimer and Parkinson’s diseases (Mattson and
Magnus, 2006) or stroke (Saito et al., 2005). Overproduction of
reactive oxygen species (ROS) leads to damage of both neurons
and astrocytes (Lin and Beal, 2006). In this study, we used an oxi-
dative stress model evoked by mitochondrial activity disruption
induced by blockade of mitochondrial complexes I and V, by using
the combination of rotenone plus oligomycin-A (Rot/oligo) (Egea
et al., 2007).
As mentioned above, the detrimental accumulation of ROS plays
an important role in multiple pathologies; therefore, cells have
developed an antioxidant armamentarium that includes a group
of antixenobiotic genes termed phase II detoxiﬁcation genes (Itoh
et al., 1999) to maintain redox homeostasis. Among these genes
is heme oxygenase-1 (HO-1), which is the rate-limiting enzyme
that degrades the pro-oxidant heme group and produces equimo-
lecular quantities of carbon monoxide (CO), iron, and biliverdin
(BV). Biliverdin is subsequently reduced to bilirubin by biliverdin
reductase. These three by-products have been related to cell pro-
tection against oxidative stress in distinct cellular models (Kim
et al., 2005; Vitali et al., 2005). HO-1 is induced in response to a
great variety of stress-inducing pathological conditions (Keyse
and Tyrrell, 1987; Nimura et al., 1996). Moreover, studies in HO-
1-deﬁcient mice have conﬁrmed that HO system is indispensable
for cell protection against oxidative stress (Poss and Tonegawa,
1997). Furthermore, it has been shown that in the post-mortem
brains of Alzheimer´s disease patients, there was a HO-1 induction
in neurons of the cerebral cortex and hippocampus and HO-1 was
co-localized with neuroﬁbrillar tangles (Schipper et al., 1995).
Therefore, it is generally accepted that HO-1 represents a physio-
logical protective mechanism against oxidative stress.
The purpose of this study was to evaluate how guanosine, a
guanine nucleoside that can be secreted under physiological or
pathological conditions, could protect cells against oxidative stress
caused by disruption of the mitochondrial respiratory chain. Here-
in we show that guanosine-induced protective effect depends on
activation of adenosine receptors and BK channels. Guanosine
can afford cytoprotection under circumstances of cell vulnerability
caused by mitochondrial disruption through an intracellular bio-
chemical pathway that implicates the activation of PI3K/Akt lead-
ing to inactivation of glycogen synthase kinase-3b (GSK-3b) and
induction of the antioxidant enzyme HO-1.
2. Materials and methods
2.1. Materials
Charybdotoxin, DPCPX (1,3-dipropyl-8-cyclopentylxanthine), F-
12 nutrient mixture, Eagle’s minimum essential medium (MEM),
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide), oligomycin A, rotenone, SB203580 [4-(4-ﬂuorophenyl)-2-(4-methylsulﬁnylphenyl)-5-(4-pyridyl)-1H-imidazole] and ZM241385
[4-(2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3a}{1,3,5}triazin-5-yla-
mino]ethylphenol] were obtained from Sigma (Madrid, Spain).
Chelerythrine and PD98059 [2-(2-amino-3-methoxyphenyl)-4H-
1-benzopyran-4-one] and LY294002 [2-(4-morpholinyl)-8phenyl-
1(4H)-benzopyran-4-4hydrochloride] were purchased from Tocris
(Biogen Cientíﬁca, Spain). Sn(IV) protoporphyrin-IX dichloride
(SnPP) was obtained from Frontier Scientiﬁc Europe (Lancashire,
UK). Penicillin/streptomycin was purchased from GIBCO (Madrid,
Spain). 20,70-dichloroﬂuorescein diacetate (H2DCFDA) was obtained
from Molecular Probes (Invitrogen, Madrid, Spain). Pyruvate and
heat-inactivated fetal bovine serum (FBS) were purchase from
Invitrogen. Bilirubin was purchase from Analisa Gold.
2.2. Culture and maintenance of SH-SY5Y cells
The neuroblastoma cell line SH-SY5Y was a kind gift from the
Centro de Biología Molecular, Universidad Autonoma de Madrid/
Consejo Superior de Investigaciones Cientiﬁcas (Madrid, Spain).
SH-SY5Y cells were maintained in a 1:1 mixture of F-12 nutrient
mixture (Ham 12) and Eagle’s MEM supplemented with 15 nones-
sential amino acids, 1 mM sodium pyruvate, 10% heat-inactivated
FBS, 100 units/ml penicillin and 100 lg/ml streptomycin (Invitro-
gen, Madrid, Spain). SH-SY5Y cells were seeded into ﬂasks contain-
ing supplemented medium, and they were maintained at 37 C in
5% CO2, humidiﬁed air. Stock cultures were passaged 1:3 twice
weekly; i.e., one plate was divided (subcultured or split) into three
plates. This procedure was performed twice a week. For assays, SH-
SY5Y cells were subcultured in 48-well plates at a seeding density
of 105 cells per well, or in 96-well plates at a seeding density of
1  105 cells per well (Cañas et al., 2007). Cells were treated with
the drugs in MEM supplemented with 1% fetal calf serum. Cells
were treated with the drugs before conﬂuence in MEM/F-12 with
1% FBS. Cells were used at a passage below 13.
2.3. Induction of cell toxicity and evaluation of cytoprotection induced
by guanosine
Cell death was induced by adding a combination of rotenone
(30 lM) plus oligomycin-A (10 lM) (Rot/oligo) for 24 h. When
present, guanosine was added to SH-SY5Y at the same time as
Rot/oligo and remained in the culture medium for the duration of
experiments (24 h). Bilirubin (50 nM)was added inmedium culture
as the same time as Rot/Oligo and remained in culture medium for
the duration of experiments (24 h). In experiments where enzyme
inhibitors, adenosinergic receptors antagonists or potassium chan-
nel blocker were tested, SH-SY5Y cells were pretreated with these
agents for 30 min prior to the addition of guanosine, which re-
mained in the incubation medium throughout the duration of the
experiment. These treatments included: the potent and selective
inhibitor of the PI3K (LY294002, 10 lM); the selective inhibitor of
the MAP kinase kinase (MEK) (PD98059, 10 lM); the inhibitor of
PKC (cheleritrine, 0,1 lM); the inhibitor of p38MAPK (SB203580,
10 lM); HO-1 inhibitor, Sn(IV) protoporphyrin IX dichloride (SnPP,
3 lM). Adenosinergic antagonists: A1 receptor antagonist (DPCPX,
100 nM); A2A receptor antagonist (ZM 241385, 50 nM); BK channel
blocker (charybdotoxin, 100 nM). LY294002, PD98059 and cheleri-
trine were dissolved in and added to the culture medium at a ﬁnal
concentration of 0.01% dimethyl sulfoxide (DMSO).
2.4. Evaluation of cell viability by MTT reduction
SH-SY5Y cell viability was evaluated 24 h after Rot/oligo or Rot/
oligo plus guanosine exposure. At the end of each experiment,
3-(4,5-dimethylthiazol-2-yl-diphenyltetrazolium bromide (MTT
Sigma Aldrich) was added to each well to a ﬁnal concentration of
Fig. 1. Guanosine protects against cell death induced by Rot/oligo in SH-SY5Y
neuroblastoma cells. (A) SH-SY5Y neuroblastoma cells were incubated for 24 h with
culture medium (basal), with increasing concentrations of GUO (0.03–1 mM) or
with 30 lM rotenone plus 10 lM oligomycin. Cellular viability was evaluated by
MTT reduction assay and was expressed as percentage of control cells representing
cells incubated for 24 h in culture medium (100% cellular viability). (B) Photomi-
crographs of control SH-SY5Y cells (Basal); cells exposed 24 h to Rot/oligo; cells co-
incubated 24 h with 1 mM guanosine (Rot/oligo + GUO).Image magniﬁcation (40X).
(C) Concentration–response curve of GUO co-incubated for 24 h with Rot/oligo. Cell
death was normalized in each individual experiment, as percentage of the
maximum cell death (Rot/oligo) that was considered as 100% (black column). Data
are mean ± SEM from ﬁve different cell batches. ⁄⁄⁄p < 0.001, represents means
signiﬁcantly different from control cells; ⁄⁄p < 0.01 represents means signiﬁcantly
different from Rot/oligo and Rot/oligo + GUO 1 mM; ##p < 0.01 represents means
signiﬁcantly different from all other groups.
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at 37 C. Then the insoluble formazan was solubilized by adding
DMSO, resulting in a colored compound which optical density
was measured in an ELISA reader (550 nm). The evaluation of
MTT reduction was performed in triplicates of four to ﬁve indepen-
dent experiments.
2.5. Measurement of ROS production
To measure cellular ROS, we have used the molecular probe
H2DCFDA (Ha et al., 1997). SH-SY5Y cells were loaded with
10 lM H2DCFDA which diffuses through the cell membrane and
is hydrolyzed by intracellular esterases to the nonﬂuorescent form
dichloroﬂuorescein (DCFH). DCFH reacts with intracellular H2O2 to
form dichloroﬂuorescin (DCF), a green ﬂuorescent dye. Fluores-
cence was measured in a ﬂuorescence microplate reader (FLUOstar
Galaxy). Wavelengths of excitation and emission were 485 and
520 nm, respectively (Egea et al., 2007). Production of ROS was
evaluated in triplicates of four independent experiments.
2.6. Immunoblotting
SH-SY5Y cells were washed once with cold phosphate-buffered
saline and lysed in 100 lL of ice-cold lysis buffer (1% Nonidet P-40,
10% glycerol, 137 mmol/L NaCl, 20 mmol/L Tris–HCl, pH 7.5, 1 lg/
mL leupeptin, 1 mmol/L phenylmethylsulfonyl ﬂuoride, 20 mmol/L
NaF, 1 mmol/L sodium pyrophosphate, and 1 mmol/L Na3VO4).
Protein (30 lg) from the cell lysates was resolved by sodium dode-
cyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and
transferred to PVDF membranes (GE Healthcare). Membranes were
incubated with the following antibodies: Anti-Akt at 1:1000, Anti-
phospho-Akt at 1:1000, Anti-phospho-Ser-9-GSK3-b at 1:1000,
Anti-GSK-3b at 1:1000 (Cell Signaling, Izasa SA, Barcelona, Spain);
anti HO-1 at 1:1000 (Chemicon, Temecula, CA, USA) anti-b-actin at
1:100,000 (Sigma, Madrid, Spain). Appropriate peroxidase-conju-
gated secondary antibodies at 1:10,000 were used to detect pro-
teins by enhanced chemiluminescence. Immunodetection was
performed in triplicates of four to six independent experiments.
2.7. Statistical analysis
Comparison among groups were performed by one-way analy-
sis of variance (ANOVA) followed by Duncan’s test if necessary,
with p < 0.05 considered to be statistically signiﬁcant.
3. Results
3.1. Guanosine protects SH-SY5Y neuroblastoma cells against Rot/
oligo-induced cell death
Treatment of SH-SY5Y neuroblastoma cells for 24 h with 30 lM
rotenone plus 10 lM oligomycin A (Rot/oligo) decreased by 70%
the cellular viability, measured as MTT reduction, when compared
to cultures incubated only with culture medium (basal). Guanosine
per se (0.03–1 mM) did not alter cellular viability at any of the con-
centrations tested (Fig. 1A).
As illustrated in the microphotographs of Fig. 1B, Rot/oligo de-
creased the number of cells when compared to cultures in basal
conditions and transformed healthy cells, isolated or grouped in
clusters, into rounded shaped cells, with a granular morphology
containing debris. SH-SY5Y cells co-incubated with 1 mM guano-
sine and Rot/oligo greatly recovered their initial density and exhib-
ited a healthier appearance.
Increasing concentrations of guanosine (0.3–1 mM) added to
the incubation medium at the same time as Rot/oligo signiﬁcantly
reduced Rot/oligo-induced cell death in SH-SY5Y cells in a concen-tration dependent fashion (Fig. 1C); maximum protection was
achieved at the concentration of 1 mM (40%, p < 0.01). Thus, this
was the concentration selected to study guanosine’s protective
mechanism of action in the following experiments.3.2. Guanosine protects against Rot/oligo-induced cell death via BK
channels and adenosine receptors modulation
We previously showed that neuroprotection afforded by guano-
sine against ischemic damage depends on BK channels activation
(Dal-Cim et al., 2011). In order to evaluate if this channel is also in-
volved in the protective effect of guanosine against mitochondrial
damage, SH-SY5Y cells were incubated with charybdotxin
(100 nM) 30 min prior to the addition of guanosine. Charybdotoxin
prevented the protective effect of guanosine against cell damage
induced by Rot/oligo (Fig. 2A).
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with adenosine A1 receptors in some situations and activation of
such receptor subtype is involved in neuroprotective effects
(Ciccarelli et al., 2000; Cunha, 2005) , we veriﬁed the role of aden-
osine A1 receptor in the protective effects triggered by guanosine in
SH-SY5Y neuroblastoma cells. The presence of A1 receptor antago-
nist (DPCPX, 100 nM) abolished neuroprotection induced by
guanosine. Interestingly, the A2A receptor antagonist (ZM241385,
50 nM) also blocked guanosine-induced protective effect (Fig. 2A).
3.3. Guanosine protects against Rot/oligo-induced cell death by
activation of the PI3K/Akt cell survival pathway and inactivation of
GSK-3b
In order to analyze the signaling pathways participating in the
neuroprotective mechanism of guanosine against Rot/oligo-Fig. 2. Evaluation of extracellular interaction sites and signaling pathways involved
in guanosine-induced neuroprotection against cell death induced by Rot/oligo in
SH-SY5Y neuroblastoma cells. (A) SH-SY5Y neuroblastoma cells were incubated for
24 h with 30 lM rotenone plus 10 lM oligomycin A (Rot/oligo) with or without
1 mM guanosine (GUO) or pre-incubated for 30 min with 100 nM DPCPX (A1
receptor antagonist), ZM241385 50 nM (A2A receptor antagonist) or Charybdotoxin
100 nM (BK channel blocker) and subsequently co-incubated 24 h with 1 mM
guanosine and Rot/oligo. Cell death was normalized in each individual experiment
as percentage of the maximum cell death (Rot/oligo) which was considered as 100%
(black column). (B) SH-SY5Y neuroblastoma cells were incubated for 24 h with
30 lM rotenone plus 10 lM oligomycin A (Rot/oligo) with or without 1 mM
guanosine (GUO) or pre-incubated for 30 min with 10 lMPD98059 (MEK inhibitor),
0.1 lM cheleritrine (chel) (PKC inhibitor), 10 lM LY294002 (PI3K inhibitor) or
10 lM SB SB203580 (p38MAPK inhibitor) and subsequently co-incubated 24 h with
1 mM guanosine and Rot/oligo. Cell death was normalized in each individual
experiment as percentage of the maximum cell death (Rot/oligo) which was
considered as 100% (black column). Data are mean ± SEM from ﬁve different cell
batches. ⁄p < 0.05 represents means signiﬁcantly different from Rot/oligo; ⁄⁄p < 0.01
represents means signiﬁcantly different from Rot/oligo; #p < 0.05 represents means
signiﬁcantly different from Rot/oligo + GUO.induced cell damage in SH-SY5Y cells, we performed experiments
with LY294002, an inhibitor of the PI3K; PD98059, an inhibitor of
MEK; cheleritrine, an inhibitor of PKC and SB203580, an inhibitor
of p38MAPK. As shown in Fig. 2B, only the inhibitor of PI3K
(LY294002, 10 lM) partially blocked the neuroprotective effect of
guanosine. Therefore these results indicate that PI3K/Akt, but not
ERK1/2, PKC or p38MAPK are participating in guanosine-induced
neuroprotection.
To further corroborate the participation of Akt, we incubated
SH-SY5Y cells during different time periods with guanosine
(1 mM) and thereafter protein extracts were obtained to measure
p-Akt by Western blot. The results showed guanosine signiﬁcantly
increased by 2.5-fold p-Akt levels after 30 min incubation; this
induction was maintained at 60 min, but it decreased after 24 h
incubation (Fig. 3A).
GSK-3b is tightly regulated by the survival pathway represented
by PI3K and its downstream effector, Ser/Thr protein kinase Akt. Akt
targets GSK-3b, also a Ser/Thr protein kinase that phosphorylated atFig. 3. Guanosine induces Akt phosphorylation and inactivation of GSK-3b by
phosphorylation of its Ser-9. (A) Representative immunoblot of Akt phosphoryla-
tion. SH-SY5Y neuroblastoma cells were incubated for 5, 15, 30 min, 1 and 24 h with
guanosine 1 mM. The histogram presents the densitometric quantiﬁcation of p-Akt/
total-Akt. (B) SH-SY5Y neuroblastoma cells were incubated for 5, 15, 30 min and 1 h
with guanosine 1 mM. The histogram presents the densitometric quantiﬁcation
anti-p-Ser9-GSK-3b and anti-total-GSK-3b. Data are mean ± SEM from four different
cell batches. ⁄p < 0.05 indicates signiﬁcantly different from basal group.
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and thereby regulates many important metabolic and signaling
proteins, structural proteins and transcription factors (Frame and
Cohen, 2001). Incubation of SH-SY5Y cells at different time intervals
with guanosine (1 mM) gradually increased p-Ser9-GSK-3b, maxi-
mum phosphorylation was also achieved after 30 min (Fig. 3B).
3.4. Participation of HO-1 in the protective mechanism of guanosine
GSK-3b has been identiﬁed as a key mediator regulating the
cross-talk between the survival signal elicited by PI3K/Akt and
the antioxidant phase II cell response (Salazar et al., 2006). In this
context, HO-1 is found among the phase II detoxiﬁcation genes.
Since induction of a moderate intracellular heme catabolism
through HO-1 represents an adaptive and protective response to
oxidative injury (Doré et al., 1999; Baranano et al., 2002), we inves-
tigated whether guanosine could be regulating this enzyme
expression. For these experiments, cells were incubated for 24 h
with basal medium alone, guanosine (1 mM), or guanosine in theFig. 4. Guanosine protects SH-SY5Y neuroblastoma cells by inducing HO-1 expression
neuroblastoma cells incubated or 24 h with guanosine (GUO) in the presence or in the abs
of HO-1 protein levels. Data are mean ± SEM from four different cell batches. ⁄⁄p < 0.0
signiﬁcantly different from guanosine group. (B) SH-SY5Y neuroblastoma cells were inc
without 1 mM GUO or pre-incubated for 30 min with 30 lM SnPP (HO-1 inhibitor) an
normalized in each individual experiment, as percentage of the maximum cell death (Rot/
different cell batches. ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001, indicates signiﬁcantly different from Rot/oli
SH-SY5Y neuroblastoma cells were incubated for 24 h with 30 lM rotenone plus 10 lM
normalized in each individual experiment, as percentage of the maximum cell death (Ro
four different cell batches.⁄p < 0.05, ⁄⁄p < 0.01, indicates signiﬁcantly different from Rot/presence of the PI3K inhibitor LY294002. Then, cell lysates were re-
solved in SDS–PAGE and analyzed by immunoblotting with anti-
HO-1. Twenty-four hours incubation with guanosine increased to
almost 3-fold the expression of HO-1. The PI3K inhibitor signiﬁ-
cantly reduced HO-1 levels induced by guanosine (Fig. 4A). There-
fore, guanosine was capable of inducing the antioxidant enzyme
HO-1 and PI3K/Akt participated in this induction.
To further analyze the involvement of HO-1 in the protective ef-
fect of guanosine, we used a HO-1 inhibitor, Sn(IV) protoporphyrin
IX (SnPP) (Marinissen et al., 2006). Indeed, SnPP was able to pre-
vent the protective effect afforded by guanosine (Fig. 4B). More-
over, bilirubin, a HO-1 product, was used to mimic HO-1 activity
induction in the neuroprotective effect of guanosine against Rot/
oligo. Bilirubin is an end product of heme catabolism and probably
the best-known endogenous antioxidant in mammals. Bilirubin
(50 nM) also counteracted citotoxicity in SH-SY5Y exposed to
Rot/oligo (Fig. 4C), conﬁrming guanosine induced endogenous
antioxidant system of HO-1 which contribute to protective effect
triggered by this nucleoside.via PI3K/Akt. (A) Representative immunoblot showing HO-1 induction in SH-SY5Y
ence of 10 lM LY294002. The histogram represents the densitometric quantiﬁcation
1 represents means signiﬁcantly different from basal groups. #p < 0.05 indicates
ubated for 24 h with 30 lM rotenone plus 10 lM oligomycin A (Rot/oligo) with or
d subsequently co-incubated 24 h with 1 mM GUO and Rot/oligo. Cell death was
oligo) which was considered as 100% (black column). Data are mean ± SEM from ﬁve
go group; ##p < 0.01 indicates signiﬁcantly different from Rot/oligo + GUO group. (C)
oligomycin A (Rot/oligo) with 1 mM GUO or with biluribin 50 nM. Cell death was
t/oligo) which was considered as 100% (black column). Data are mean ± SEM from
oligo group.
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Since Rot/oligo are potent inhibitors of the complex I and V of
the respiratory chain, respectively, and cause oxidative stress (Egea
et al., 2007), we measured ROS generation with the ﬂuorescent
probe H2DCFDA. At the end of the 24 h period with Rot/oligo, cells
were loaded with 10 lM H2DCFDA for 20 min. Cells exposed to
Rot/oligo increased ROS production to 293%. When cells were
co-incubated with guanosine and Rot/oligo for 24 h, the amount
of ROS produced by cells was reduced to basal levels. Interestingly,
LY294002 abolished the reduction of ROS elicited by guanosine
(Fig. 5). Taken together, these results indicate that guanosine pro-
tects SH-SY5Y cells from mitochondrial oxidative stress by a mech-
anism that implicates PI3K/Akt pathway.Fig. 6. Schematical representation of putative protective mechanism of guanosine.
Guanosine-induced neuroprotection seems to involve modulation of adenosine A1
and A2A receptors and BK channels activation. Guanosine activates PI3K/Akt/GSK-3b
pathway leading to HO-1 induction which protect against ROS production caused
by blockade of mitochondrial complexes I and V with rotenone and oligomycin A,
respectively. The PI3K inhibitor (LY294002) and HO-1 inhibitor (SnPP) blocked the
protective effect induced by guanosine.4. Discussion
Central to this study is guanosine protects cells from mitochon-
drial oxidative stress by inducing the antioxidant enzyme HO-1 via
PI3K/Akt/GSk-3b pathway Fig. 6.
Mitochondrial dysfunction and bioenergetic deﬁciency is clo-
sely linked to pathogenesis of many neurodegenerative disorders.
Mitochondria play a variety of roles by integrating extracellular
signals and executing important intracellular events in neuronal
survival and death. In this context, the regulation of mitochondrial
function via therapeutic approaches may exert some salutary and
neuroprotective mechanisms. In this study we have caused inter-
ruption of the respiratory chain at complexes I (rotenone) and V
(oligomycin-A) that causes mitochondrial depolarization, increases
ROS production, and a vicious circle leading to cell death (Egea
et al., 2007). The oxidative damage induced by Rot/oligo pro-
foundly affected cellular viability of SH-SY5Y neuroblastoma cells,
as observed by a signiﬁcant impairment in MTT reduction, as well
as by morphological alterations consistent with cell death. MTT
reduction assay can also be considered an approach to evaluate cell
proliferation. However, in a previous study, incubation of SH-SY5Y
cells with the same concentration of Rot/oligo and time incubation
used in our study, can also induce LDH leakage (Cañas et al., 2007),
indicating Rot/oligo induces cell death and does not seem to inter-
fere with cell proliferation. Under these experimental conditions,
guanosine was able to reduce cell death in a concentration-depen-
dent manner. Studies evaluating a protective role of guanosineFig. 5. Guanosine inhibits mitochondrial ROS production elicited by Rot/oligo in
SH-SY5Y neuroblastoma cells. SH-SY5Y neuroblastoma cells were incubated for
24 h with 30 lM rotenone plus 10 lM oligomycin A (Rot/oligo) with or without
1 mM guanosine (GUO). Cells were pre-incubated for 30 min with 10 lM LY294002
(PI3K inhibitor) and subsequently co-incubated 24 h with 1 mM guanosine and Rot/
oligo. Data are means ± SEM from four different cell batches. ⁄p < 0.05 represents
means signiﬁcantly different from all other groups. ##p < 0.01 represents means
signiﬁcantly different from Rot/oligo group.against cell death induced by apoptosis in SH-SY5Y cell culture
have shown that this effect is observable at concentrations be-
tween 100 lm and 300 lM (Di Iorio et al., 2004; Pettifer et al.,
2004, 2007). Here we observed that 1 mM guanosine was the most
effective concentration of guanosine against cell death induced by
Rot/oligo. This concentration can be justiﬁed by the high amount of
necrotic cell death induced by Rot/oligo after 24 h of treatment
(Egea et al., 2007; Parada et al., 2010) and thus a greater concentra-
tion of guanosine was necessary to induced protection.
Identiﬁcation of molecular targets for guanosine is of funda-
mental relevance, since guanosine receptors are poorly character-
ized (Tasca et al., 1999; Traversa et al., 2002; Volpini et al.,
2011). Astrocytic cells subjected to hypoxia/hypoglicemia release
guanosine (Ciccarelli et al., 1999), whose levels remain high for
several days afterwards (Uemura et al., 1991). Therefore, in a path-
ological scenario, guanosine could be released locally from astro-
cytes to provide protection under circumstances involving
neuronal injury. Previous evidence showed guanosine protective
effects were mediated by potassium channels (Oleskovicz et al.,
2008), which were identiﬁed as BK channels in guanosine-induced
neuroprotection in hippocampal slices subject to oxygen/glucose
deprivation (Dal-Cim et al., 2011). The evaluation of a putative
interaction site of guanosine in SH-SY5Y cells, in order to trigger
this protective effect, also demonstrated dependence on BK chan-
nels activity. Since BK channels promote a negative feedback regu-
lation of Ca2+ inﬂux via voltage-gated-Ca2+ channels, regulation of
cellular excitability and neurotransmitter release (Hu et al., 2001;
Ghatta et al., 2006), it is feasible guanosine effect on BK channels
may contribute to ionic homeostasis and reduction of ROS
production.
However, some studies have claimed a putative interaction of
guanosine on A1 adenosine receptors (Thauerer et al., 2012). Aden-
osine A1 receptors regulate the activity of cell membrane Ca2+
channels, K+ channels, adenylate cyclase and phospholipase C (Pal-
mer and Stiles, 1995), and it is associated to control of neurodegen-
erative process (Cunha, 2005). Thus, the possible interaction of
guanosine with A1 receptors observed here could result in an intra-
cellular signaling leading to cellular protection. Surprisingly, it was
observed the A2A receptor antagonist, ZM241385, was also able to
T. Dal-Cim et al. / Neurochemistry International 61 (2012) 397–404 403prevent guanosine effect. Despite A1 and A2A receptors trigger
opposing signal transduction and these receptors can interact
forming A1-A2A receptor heterodimers with antagonic actions
(Ciruela et al., 2006), we have previously observed guanosine-in-
duced trophic effects on cerebellar neurons depend on both A1
and A2A adenosine receptors activation (Tasca et al., 2010). There-
fore, the exact mechanism of interaction or modulation of BK and
adenosine receptors through guanosine-induced neuroprotection
remains to be unraveled.
In this study, we focused in understanding signaling pathways
related to the protective mechanism of action of guanosine. The
putative participation of PI3K, MAPKs and PKC cascades was eval-
uated because they have been described as key elements of signal
transduction involved in cell proliferation, differentiation and
stress response (Cantley, 2002; Cañas et al., 2007). Guanosine has
proven to induce trophic effects by a mechanism that implicates
activation of MAPK and PKC (Decker et al., 2007) and promote neu-
roprotection via PI3K/Akt (Di Iorio et al., 2004; Pettifer et al., 2004;
Oleskovicz et al., 2008; Dal-Cim et al., 2011). Based on these evi-
dences, we looked for the involvement of PI3K, MEK, PKC and
p38MAPK in the protective effect of guanosine against Rot/oligo-in-
duced cell death. Neither MEK, PKC or p38MAPK inhibition altered
the protective effect of guanosine. However, inhibition of PI3K/
Akt pathway by LY294002, partially abolished the protective effect
of guanosine. Moreover, guanosine induced an increased Akt phos-
phorylation and LY294002 also prevented reduction of ROS pro-
duction promoted by guanosine in Rot/oligo treated cells. Taken
together, these data reinforce the idea PI3K/Akt pathway is impli-
cated in the protective effect of guanosine.
Akt phosphorylates its substrate GSK-3b at the position Ser-9
and this phosphorylation inactivates GSK-3b (Stambolic and
Woodgett, 1994). GSK-3b inhibition has been shown to be protec-
tive against a plethora of neurological insults (Manji et al., 1999;
Endo et al., 2007), suggesting its inhibition can improve brain cell
survival. Guanosine induces increased levels of p-Ser9-GSK-3b,
showing inhibition of its activity. These results agree with previous
data from our group, which demonstrate that guanosine protects
against glutamate-induced cell death in rat hippocampal slices
by activation of PI3K/Akt and subsequent inactivation of GSK-3b
(Molz et al., 2011).
Inhibition of GSK-3b increases Nrf2 transcriptional activity
(Rojo et al., 2008) which, in turn, regulates HO-1 transcription
(Alam and Cook, 2003). HO-1 is a stress defense enzyme with
anti-inﬂammatory and antioxidant properties (Lee and Chau,
2002; Salinas et al., 2003). Guanosine increased HO-1 expression,
an effect related to guanosine-induced protection, since HO-1 inhi-
bition with SnPP prevented guanosine effect on cell viability. A pre-
vious study has also shown that guanosine can promote HO-1
expression, although this effect was related to neurite outgrowth
induction in PC12 cells (Bau et al., 2005), but not cellular protec-
tion as showed.
Interesting, the upregulation of HO-1 induced by guanosine, as
well as its effect on ROS production was fully prevented by a PI3K/
Akt inhibitor, indicating this pathway directly participates in
induction of this antioxidant enzyme. The participation of PI3K/
Akt in regulating HO-1 induction has been previously described
(Cañas et al., 2007; Hwang and Jeong, 2010; Parada et al., 2010).
Modest induction of HO-1 activity results in a modest increase
in biliverdin/bilirubin levels. Data in the literature have demon-
strated a protective role for very low nanomolar concentrations
of bilirubin in cultured rat primary hippocampal neurons exposed
to H2O2 and to ethanol-induced neurotoxicity (Doré et al., 1999; Ku
et al., 2006). In this study, bilirubin protected against Rot/oligo-in-
duced cell death, as observed with guanosine. Bilirubin is an
important endogenous antioxidant and may be particularly
important as a cytoprotectant for tissues with relatively weakendogenous antioxidant defenses such as the nervous system (Ew-
ing et al., 1992). These ﬁndings reinforce the idea that guanosine-
induced protection against excessive ROS production elicited by
Rot/oligo could be related to its ability to induced HO-1 antioxi-
dant activity and, could thus restore balance between ROS produc-
tion and scavenging.
In conclusion, guanosine can reduce oxidative stress induced by
mitochondrial disruption due to a mechanism involving PI3K/Akt/
GSK-3b pathway and induction of the antioxidant enzyme HO-1.
Thus, endogenous compounds that protect against oxidative stress
can be considered as new strategies to protect neurons in CNS
pathologies.
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